Stock DNA
Specialty Chemicals
USD 397 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.09
-10.22%
0.84
Revenue and Profits:
Net Sales:
43 Million
(Quarterly Results - Jun 2025)
Net Profit:
3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
78.51%
0%
78.51%
6 Months
46.94%
0%
46.94%
1 Year
245.6%
0%
245.6%
2 Years
39.35%
0%
39.35%
3 Years
-23.4%
0%
-23.4%
4 Years
-73.63%
0%
-73.63%
5 Years
64.89%
0%
64.89%
Gevo, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
35.11%
EBIT Growth (5y)
-26.85%
EBIT to Interest (avg)
-32.79
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
33.64%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.59
EV to EBIT
-4.85
EV to EBITDA
-6.45
EV to Capital Employed
0.66
EV to Sales
9.05
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-13.71%
ROE (Latest)
-15.36%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 35 Schemes (19.33%)
Foreign Institutions
Held by 56 Foreign Institutions (8.27%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
43.40
29.10
49.14%
Operating Profit (PBDIT) excl Other Income
13.00
-10.10
228.71%
Interest
4.30
3.30
30.30%
Exceptional Items
0.00
-4.40
100.00%
Consolidate Net Profit
2.70
-21.80
112.39%
Operating Profit Margin (Excl OI)
133.50%
-539.40%
67.29%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 49.14% vs 410.53% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 112.39% vs -23.86% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
16.90
17.20
-1.74%
Operating Profit (PBDIT) excl Other Income
-67.60
-62.80
-7.64%
Interest
3.90
2.20
77.27%
Exceptional Items
-4.90
0.00
Consolidate Net Profit
-78.60
-66.20
-18.73%
Operating Profit Margin (Excl OI)
-5,077.90%
-4,757.80%
-32.01%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -1.74% vs 1,333.33% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -18.73% vs 32.45% in Dec 2023
About Gevo, Inc. 
Gevo, Inc.
Specialty Chemicals
Gevo Inc. is engaged in commercializing jet fuel, gasoline and diesel fuel. The Company’s fermentation yeast biocatalyst produces isobutanol through fermentation of renewable plant biomass. It operates through two segments: Gevo, Inc. (Gevo) segment and Gevo Development/Agri-Energy segment. Gevo segment is responsible for research and development activities related to the production of isobutanol, including the development of the Company's biocatalysts, the production and sale of renewable jet and other fuels, the Retrofit process and the generation of chemicals and biofuels. The Gevo Development/Agri-Energy segment is responsible for the operation of the Luverne Facility and the production of ethanol, isobutanol and related products. Its products include renewable gasoline, renewable biodiesel, isooctane, sustainable aviation fuel (SAF), isobutylene, ethanol and animal feed.
Company Coordinates 
Company Details
Building C, 345 Inverness Dr S Ste 310 , ENGLEWOOD CO : 80112-5892
Registrar Details






